Biopharmaceutical company that is creating innovative drugs for major diseases based on important discoveries emerging from the field of Epigenetics
- Year invested 2009
- Investment Stage Early
- Sectors
- Investment Status Historic
- Website epizyme.com
- Company Status IPO/Public (NASDAQ: EPZM)